October 1, 2012
Ashley Gould, 23andMe's Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative neoplasms, or MPNs. As a testament to the passion of the people who’ve enrolled in our MPN Research [...]
March 9, 2012
In August of last year, I wrote with hope and excitement about the launch of the 23andMe MPN Research Initiative because my father, Harvey, suffers from myelofibrosis. On March 5, 23andMe scientist Bethann Hromatka posted a SNPWatch report about the association between the JAK2 gene and MPNs. 23andMe [...]
July 20, 2010
The FDA/CDRH Public Meeting on Oversight of Laboratory Developed Tests (LDTs) took place yesterday and today (July 19 and 20) in Washington, DC. Webcasts of both days will be available from the FDA for the next year. 23andMe's President and Co-Founder Anne Wojcicki spoke about the promise and power of [...]
